Garner Health

Zus is a next-generation shared health data platform designed to solve one of healthcare's most persistent problems: fragmented patient information. Every day, clinicians struggle to piece together a complete picture of their patients' health across multiple systems, hospitals, and specialists - leading to redundant tests, medical errors, and delayed care. Zus exists to fix this by building a unified data layer that aggregates patient clinical history from health information exchanges and other data networks, then translates that information into user-friendly insights at the point of care. The company's flagship product, the Zus Aggregated Profile (ZAP), provides a single, shareable view of a patient that makes it quick and easy for care teams to understand all of a patient's recent and ongoing healthcare interactions. Founded in 2020 by Jonathan Bush, co-founder and former CEO of athenahealth, Zus partners with healthcare innovators to help them build up, not around, the healthcare data problem. The platform delivers data via API, embedded components, and direct EHR integrations, enabling healthcare organizations to prevent hospital stays, boost team efficiency, and deliver better-informed, holistic care without asking patients to fill out dreaded clipboards or endure manual record chasing.

In 2017, AJ Loiacono and Ryan Kelly founded Capital Rx with a singular mission: to transform the broken prescription drug pricing system that was costing patients and plans billions. They recognized early on that the traditional pharmacy benefit manager (PBM) model was riddled with hidden fees, opaque pricing, and misaligned incentives that prioritized profits over patient care. Rather than simply building another layer of technology on top of existing systems, they made the bold decision to become a full-service PBM themselves, developing their own platform from the ground up that would enable unprecedented transparency and efficiency. What began as a focused effort to revolutionize pharmacy benefits quickly evolved into something much larger. As they built their technology platform, they realized that to truly transform healthcare, they needed to address the entire health benefits ecosystem - not just pharmacy. They developed Judi®, an open, secure, and scalable enterprise health platform that could unify claims processing across pharmacy, medical, dental, and vision benefits. This breakthrough platform enabled the launch of Judi Health™, the industry's first Unified Claims Processing™ platform, which eliminates administrative waste and redundancies by bringing all benefits together in one system. In 2025, Capital Rx rebranded to Judi Health to reflect this expansion beyond pharmacy, marking the company's evolution into a full-stack health infrastructure platform that's building the digital foundation needed to make healthcare accessible, affordable, and transparent for all.

At Highmark Health, we believe in the power of collaboration to transform healthcare from a fragmented system into a unified, compassionate experience. Our team of more than 35,000 people works together across eight companies to create remarkable health experiences that free people to be their best. We operate as a blended health organization, meaning our teams don't work in silos - they collaborate across health insurance, hospital systems, dental care, vision services, and technology solutions to provide seamless, coordinated care for our members and patients. We're deeply rooted in our communities, with a legacy of compassionate care that spans more than 175 years. This tradition of giving back isn't just a policy - it's woven into our daily culture. Our team members thrive in an environment that values purpose-driven work, continuous innovation, and meaningful community impact. We challenge the status quo at every touchpoint, embracing breakthrough ideas and new visionaries who champion change in the American healthcare system. Together, we're building something stronger than the sum of our parts - a healthcare experience that genuinely cares for people.

Guardant Health is a leading precision oncology company transforming cancer care through the power of liquid biopsy. With over 500,000 blood tests performed by 12,000 doctors to date, the company provides critical insights that help clinicians discover cancer early and select the best treatment paths. Guardant's proprietary blood tests span all stages of cancer - from screening to advanced disease - and have achieved historic milestones, including securing the first FDA-approved blood tests for comprehensive genomic testing and primary colorectal cancer screening. The Shield test represents a breakthrough in cancer detection, offering a convenient blood draw option that has been approved for adults 45 and older at average risk for colorectal cancer. Beyond diagnostics, Guardant Health enables biopharma partners to accelerate drug development through advanced genomic profiling and real-world evidence. Founded in 2012 and headquartered in Palo Alto, California, the company operates globally with teams across the Americas, Europe, Asia, Middle East, and Africa. Guardant's mission to conquer cancer with data drives every aspect of their work, from developing breakthrough tests like Guardant360 CDx and Guardant Reveal to maintaining rigorous quality standards in their CLIA-certified, CAP-accredited laboratories. Their comprehensive approach spans cancer screening, early-stage detection, advanced cancer management, and biopharma solutions - all focused on giving patients more time free from cancer.

Zócalo Health is a Latino-founded virtual primary care provider delivering culturally-competent healthcare services to the Latino community. Founded in 2021 by Erik Cardenas and Mariza Hardin, the company addresses the significant healthcare disparities faced by over 62 million Latinos in the United States. With 1 in 3 Latinos uninsured and 50% more likely to experience delays accessing medical care compared to non-Hispanic whites, Zócalo Health was built to eliminate barriers to accessing healthcare services through a model that is by Latinos, for Latinos. The company combines modern technology with cultural traditions to provide comprehensive care including virtual primary and urgent care, behavioral health services, and social support through community health workers known as promotoras de salud. Backed by $5 million in seed funding from healthcare and social impact investors, Zócalo Health now serves patients across California, Texas, Maryland, and Washington. Their care model integrates bilingual providers, mobile health apps for iOS and Android, and community-based engagement to deliver whole-person care that meets patients where they are - virtually, in their homes, and within their neighborhoods.

As a "recovering radiologist" from Mayo Clinic and Harvard, Dr. Jeremy Friese experienced the struggles of prior authorization firsthand. After learning that payers also despised the cumbersome, costly process, he set out on a mission to bring providers and payers together to automate the problem so patients can get the care they deserve while reducing the costs and waste that plague our healthcare system. Six years ago, the team began building an artificial intelligence solution to solve prior authorization for all medical specialties. After a couple acquisitions and tens of millions of dollars invested in the technology, Dr. Friese returned with Humata Health and an amazing team. While they have helped millions of patients, the time is now to deliver truly "frictionless prior authorization" at scale so every patient gets the care they deserve and the process becomes touchless. As a physician-led company, Humata is solely focused on solving the complexities of prior authorization by seamlessly connecting payers and providers, leveraging deep clinical expertise and advanced AI to streamline approvals, reduce administrative burden, and ensure patients receive timely care.